Peptide Labeling

Overview

Peptide labeling is the attachment of a detectable reporter group to a peptide sequence. Labels enable researchers to track peptide localization, quantify binding to targets, measure pharmacokinetics in animals, visualize uptake in cells, and perform high-throughput screening. The choice of label, position, and chemistry influences the peptide's activity, stability, solubility, and immunogenicity, so labeling strategy requires careful design.

Common Label Types

Fluorescent tags

• Fluorescein (FITC, FAM) — classic green fluorophore, pH-sensitive
• Rhodamines and TAMRAs — photostable red-orange fluorophores
• Cyanine dyes (Cy3, Cy5, Cy7) — high quantum yield, far-red options
• Alexa Fluor series — bright, pH-insensitive alternatives
• BODIPY dyes — narrow emission, widely used for live-cell imaging
• NBD — small, environment-sensitive probe

Fluorescent peptides support confocal imaging, flow cytometry, and fluorescence polarization binding assays.

Radioisotope labels

• ³H (tritium) — low-energy β emitter, long half-life
• ¹⁴C — long-half-life β emitter useful for metabolism studies
• ¹²⁵I — γ emitter for radioligand binding; typically attached via iodination of tyrosine
• ³²P and ³³P — for phosphorylated peptide tracking
• ⁶⁸Ga, ⁶⁴Cu, ¹⁸F — positron emitters for PET imaging
• ⁹⁹ᵐTc — single-photon emission for SPECT
• ¹⁷⁷Lu, ²²⁵Ac — therapeutic radionuclides for peptide-receptor radionuclide therapy

Radiolabels allow extreme sensitivity but require radiation safety infrastructure.

Affinity handles

• Biotin — binds streptavidin with ~10⁻¹⁵ Kd for pull-downs, blot detection, and ELISA
• His-tags — for immobilized metal affinity chromatography during purification
• FLAG, HA, Myc epitope tags — for immunoprecipitation
• SNAP-tag, Halo-tag — self-labeling enzymes enabling flexible fluorophore choice

Isotopic mass labels

• Stable heavy isotopes (²H, ¹³C, ¹⁵N, ¹⁸O) — enable relative and absolute quantification by mass spec analysis
• TMT, iTRAQ — isobaric tags for multiplexed proteomics
• SILAC — metabolic labeling of cultured cells

Labeling Chemistries

Amine-reactive (lysine or N-terminus)

• NHS esters — fast, efficient, but not site-specific
• Sulfo-NHS esters — water-soluble variants
• Imidoesters (DMP, DMS) — preserve positive charge

Thiol-reactive (cysteine)

• Maleimides — selective at pH 6.5–7.5
• Iodoacetamides — irreversible alkylation
• Disulfide exchange — reversible linkage

Click chemistry

• Azide + alkyne (CuAAC or strain-promoted)
• Tetrazine + trans-cyclooctene (fastest bioorthogonal chemistry)

Click chemistry allows site-specific labeling when a clickable unnatural amino acid is incorporated during synthesis.

Enzymatic labeling

• Sortase A — attaches probes to LPXTG motifs
• Transglutaminase — modifies glutamine residues
• Formylglycine-generating enzyme for aldehyde tags

Tyrosine modification

• Iodination with chloramine-T or Iodogen for ¹²⁵I
• Diazonium coupling for bioorthogonal handles

Design Considerations

• Position of label — N- vs. C-terminus vs. side chain. Avoid regions critical for receptor binding.
• Linker length and flexibility — short rigid linkers for FRET pairs, longer flexible linkers for affinity retention
• Hydrophilicity — bulky hydrophobic labels can reduce solubility and increase aggregation; PEG spacers help
• Charge — labels with multiple charges can shift zwitterion balance and alter membrane permeability
• Metabolic stability — label must survive protease exposure long enough for the experiment
• Assay validation — confirm labeled peptide retains binding affinity comparable to unlabeled analog

Common Applications

Binding assays

Fluorescently labeled peptides drive fluorescence polarization, FRET, and biolayer interferometry measurements of receptor dissociation constant.

Cellular imaging

Confocal and super-resolution microscopy tracks labeled peptide internalization, receptor trafficking, and subcellular localization.

Pharmacokinetics

Radiolabeled or fluorescently labeled peptides quantify distribution, half-life, and clearance in animal models.

In vivo imaging and therapy

Radiolabeled somatostatin analogs (⁶⁸Ga-DOTATATE imaging, ¹⁷⁷Lu-DOTATATE therapy) are clinically approved. Many other peptide-radionuclide conjugates are in development.

Immunoassay

Biotinylated peptides serve as capture or detection reagents in ELISA and western blot protocols, and in surface immobilization for surface plasmon resonance.

Quality Control

After labeling, verify:

• Purity — HPLC or HPLC purification post-conjugation
• Mass — mass spec analysis confirms expected addition
• Degree of labeling — UV-Vis or fluorescence-based measurement of label:peptide ratio
• Activity — dose-response assay against reference unlabeled peptide

Summary

Peptide labeling transforms peptides into trackable, quantifiable probes. Selecting the right label chemistry and position — while preserving biological activity — is essential to meaningful results in imaging, binding, pharmacokinetics, and therapy. Careful QC ensures the labeled product behaves like its unlabeled parent in the system of interest.